Akums Drugs & Pharmaceuticals Shareholding Pattern & Promoter Holding

Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026

As of Sep 2026, promoters hold 75.26% of Akums Drugs & Pharmaceuticals, FIIs hold 4.50%, DIIs hold 11.09% and the public holds 6.42%. Promoter holding was unchanged from Jun 2026.

Get an alert when Akums Drugs & Pharmaceuticals reports results or its shareholding changes. Free account.

Promoters

75.26%

unchanged QoQ

FIIs

4.50%

+2.59 pp QoQ

DIIs

11.09%

−2.35 pp QoQ

Public

6.42%

−0.25 pp QoQ

Akums Drugs & Pharmaceuticals shareholding, quarter by quarter

QuarterPromotersFIIsDIIsPublicOthersShareholders
Sep 202675.26%4.50%11.09%6.42%2.73%67,618
Jun 202675.26%1.91%13.44%6.67%2.73%70,289
Mar 202675.26%1.38%14.36%6.29%2.73%72,589
Dec 202575.26%1.14%14.41%6.45%2.73%76,869
Sep 202575.26%2.27%9.28%10.46%2.73%75,365
Jun 202575.26%4.24%8.85%8.92%2.73%69,424
Mar 202575.26%5.77%7.39%8.84%2.73%69,366
Dec 202475.26%6.36%6.99%8.64%2.73%68,410
Sep 202475.26%7.34%7.53%7.14%2.73%57,531

Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others) · Others. Percentages of total shares, from the quarterly pattern filed with the exchanges.

Value of the promoter stake

At a market capitalisation of ₹11.69k cr, the promoter group's 75.26% stake is worth ₹8.80k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.

Promoter holding in Pharmaceuticals & Biotechnology peers

Akums Drugs & Pharmaceuticals shareholding: common questions

What is the promoter holding in Akums Drugs & Pharmaceuticals?

Promoters hold 75.26% of Akums Drugs & Pharmaceuticals as of Sep 2026. Their stake was unchanged from Jun 2026.

How much do FIIs hold in Akums Drugs & Pharmaceuticals?

Foreign institutional investors (FIIs) held 4.50% of Akums Drugs & Pharmaceuticals in Sep 2026, +2.59 pp versus Jun 2026.

How much do mutual funds and other DIIs hold in Akums Drugs & Pharmaceuticals?

Domestic institutional investors (DIIs), which include mutual funds and insurers, held 11.09% of Akums Drugs & Pharmaceuticals in Sep 2026, −2.35 pp versus Jun 2026.

Is the promoter holding in Akums Drugs & Pharmaceuticals pledged?

The latest disclosed shareholding pattern shows no pledged promoter shares in Akums Drugs & Pharmaceuticals.

How has Akums Drugs & Pharmaceuticals's promoter holding changed in the last year?

Promoter holding moved from 75.26% in Sep 2025 to 75.26% in Sep 2026 (unchanged).

How many shareholders does Akums Drugs & Pharmaceuticals have?

Akums Drugs & Pharmaceuticals had 67,618 shareholders in Sep 2026, compared with 70,289 in Jun 2026.